Transcriptional regulation of the human FPR2/ALX gene: Evidence of a heritable genetic variant that impairs promoter activity

Felice Simiele, Antonio Recchiuti, Domenico Mattoscio, Antonella De Luca, Eleonora Cianci, Sara Franchi, Valentina Gatta, Alessandro Parolari, Josè Pablo Werba, Marina Camera, Bartolo Favaloro, Mario Romano

Research output: Contribution to journalArticle

Abstract

Lipoxin (LX) A 4, a main endogenous stopsignal of inflammation, activates the G-protein-coupled receptor FPR2/ALX, which triggers potent anti-inflammatory signaling in vivo. Thus, the regulation of FPR2/ALX expression may have pathophysiological and therapeutic relevance. Here, we mapped a nucleotide sequence with strong FPR2/ALX promoter activity. Chromatin immunoprecipitation revealed specificity protein 1 (Sp1) binding to the core promoter. Site-directed mutagenesis of the Sp1 cis-acting element and Sp1 overexpression established that this transcription factor is key for maximal promoter activity, which is instead suppressed by DNA methylation. LXA 4 enhanced FPR2/ALX promoter activity (+74%) and mRNA expression (+87.5%) in MDAMB231 cells. A single nucleotide mutation (A/G) was detected in the core promoter of one subject with history of cardiovascular disease and of his two daughters. This mutation reduced by ∼35-90% the promoter activity in vitro. Moreover, neutrophils from individuals carrying the A/G variant displayed ∼10- and 3-fold reduction in FPR2/ALX mRNA and protein, respectively, compared with cells from their relatives or healthy volunteers expressing the wild-type allele. These results uncover FPR2/ ALX transcriptional regulation and provide the first evidence of mutations that affect FPR2/ALX transcription, thus opening new opportunities for the understanding of the LXA 4-FPR2/ALX axis in human disease.

Original languageEnglish
Pages (from-to)1323-1333
Number of pages11
JournalFASEB Journal
Volume26
Issue number3
DOIs
Publication statusPublished - Mar 2012

Fingerprint

Genes
Mutation
Lipoxins
Messenger RNA
Proteins
Nucleotides
Chromatin Immunoprecipitation
DNA Methylation
G-Protein-Coupled Receptors
Site-Directed Mutagenesis
Nuclear Family
Protein Binding
Mutagenesis
Healthy Volunteers
Neutrophils
Anti-Inflammatory Agents
Transcription Factors
Cardiovascular Diseases
Transcription
Alleles

Keywords

  • Inflammation
  • Lipoxin A receptor
  • Methylation
  • Polymorphism
  • Sp1

ASJC Scopus subject areas

  • Biochemistry
  • Biotechnology
  • Genetics
  • Molecular Biology

Cite this

Simiele, F., Recchiuti, A., Mattoscio, D., De Luca, A., Cianci, E., Franchi, S., ... Romano, M. (2012). Transcriptional regulation of the human FPR2/ALX gene: Evidence of a heritable genetic variant that impairs promoter activity. FASEB Journal, 26(3), 1323-1333. https://doi.org/10.1096/fj.11-198069

Transcriptional regulation of the human FPR2/ALX gene : Evidence of a heritable genetic variant that impairs promoter activity. / Simiele, Felice; Recchiuti, Antonio; Mattoscio, Domenico; De Luca, Antonella; Cianci, Eleonora; Franchi, Sara; Gatta, Valentina; Parolari, Alessandro; Werba, Josè Pablo; Camera, Marina; Favaloro, Bartolo; Romano, Mario.

In: FASEB Journal, Vol. 26, No. 3, 03.2012, p. 1323-1333.

Research output: Contribution to journalArticle

Simiele, F, Recchiuti, A, Mattoscio, D, De Luca, A, Cianci, E, Franchi, S, Gatta, V, Parolari, A, Werba, JP, Camera, M, Favaloro, B & Romano, M 2012, 'Transcriptional regulation of the human FPR2/ALX gene: Evidence of a heritable genetic variant that impairs promoter activity', FASEB Journal, vol. 26, no. 3, pp. 1323-1333. https://doi.org/10.1096/fj.11-198069
Simiele, Felice ; Recchiuti, Antonio ; Mattoscio, Domenico ; De Luca, Antonella ; Cianci, Eleonora ; Franchi, Sara ; Gatta, Valentina ; Parolari, Alessandro ; Werba, Josè Pablo ; Camera, Marina ; Favaloro, Bartolo ; Romano, Mario. / Transcriptional regulation of the human FPR2/ALX gene : Evidence of a heritable genetic variant that impairs promoter activity. In: FASEB Journal. 2012 ; Vol. 26, No. 3. pp. 1323-1333.
@article{4ed1104ace6e4889a93ebfe9565e5b62,
title = "Transcriptional regulation of the human FPR2/ALX gene: Evidence of a heritable genetic variant that impairs promoter activity",
abstract = "Lipoxin (LX) A 4, a main endogenous stopsignal of inflammation, activates the G-protein-coupled receptor FPR2/ALX, which triggers potent anti-inflammatory signaling in vivo. Thus, the regulation of FPR2/ALX expression may have pathophysiological and therapeutic relevance. Here, we mapped a nucleotide sequence with strong FPR2/ALX promoter activity. Chromatin immunoprecipitation revealed specificity protein 1 (Sp1) binding to the core promoter. Site-directed mutagenesis of the Sp1 cis-acting element and Sp1 overexpression established that this transcription factor is key for maximal promoter activity, which is instead suppressed by DNA methylation. LXA 4 enhanced FPR2/ALX promoter activity (+74{\%}) and mRNA expression (+87.5{\%}) in MDAMB231 cells. A single nucleotide mutation (A/G) was detected in the core promoter of one subject with history of cardiovascular disease and of his two daughters. This mutation reduced by ∼35-90{\%} the promoter activity in vitro. Moreover, neutrophils from individuals carrying the A/G variant displayed ∼10- and 3-fold reduction in FPR2/ALX mRNA and protein, respectively, compared with cells from their relatives or healthy volunteers expressing the wild-type allele. These results uncover FPR2/ ALX transcriptional regulation and provide the first evidence of mutations that affect FPR2/ALX transcription, thus opening new opportunities for the understanding of the LXA 4-FPR2/ALX axis in human disease.",
keywords = "Inflammation, Lipoxin A receptor, Methylation, Polymorphism, Sp1",
author = "Felice Simiele and Antonio Recchiuti and Domenico Mattoscio and {De Luca}, Antonella and Eleonora Cianci and Sara Franchi and Valentina Gatta and Alessandro Parolari and Werba, {Jos{\`e} Pablo} and Marina Camera and Bartolo Favaloro and Mario Romano",
year = "2012",
month = "3",
doi = "10.1096/fj.11-198069",
language = "English",
volume = "26",
pages = "1323--1333",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "3",

}

TY - JOUR

T1 - Transcriptional regulation of the human FPR2/ALX gene

T2 - Evidence of a heritable genetic variant that impairs promoter activity

AU - Simiele, Felice

AU - Recchiuti, Antonio

AU - Mattoscio, Domenico

AU - De Luca, Antonella

AU - Cianci, Eleonora

AU - Franchi, Sara

AU - Gatta, Valentina

AU - Parolari, Alessandro

AU - Werba, Josè Pablo

AU - Camera, Marina

AU - Favaloro, Bartolo

AU - Romano, Mario

PY - 2012/3

Y1 - 2012/3

N2 - Lipoxin (LX) A 4, a main endogenous stopsignal of inflammation, activates the G-protein-coupled receptor FPR2/ALX, which triggers potent anti-inflammatory signaling in vivo. Thus, the regulation of FPR2/ALX expression may have pathophysiological and therapeutic relevance. Here, we mapped a nucleotide sequence with strong FPR2/ALX promoter activity. Chromatin immunoprecipitation revealed specificity protein 1 (Sp1) binding to the core promoter. Site-directed mutagenesis of the Sp1 cis-acting element and Sp1 overexpression established that this transcription factor is key for maximal promoter activity, which is instead suppressed by DNA methylation. LXA 4 enhanced FPR2/ALX promoter activity (+74%) and mRNA expression (+87.5%) in MDAMB231 cells. A single nucleotide mutation (A/G) was detected in the core promoter of one subject with history of cardiovascular disease and of his two daughters. This mutation reduced by ∼35-90% the promoter activity in vitro. Moreover, neutrophils from individuals carrying the A/G variant displayed ∼10- and 3-fold reduction in FPR2/ALX mRNA and protein, respectively, compared with cells from their relatives or healthy volunteers expressing the wild-type allele. These results uncover FPR2/ ALX transcriptional regulation and provide the first evidence of mutations that affect FPR2/ALX transcription, thus opening new opportunities for the understanding of the LXA 4-FPR2/ALX axis in human disease.

AB - Lipoxin (LX) A 4, a main endogenous stopsignal of inflammation, activates the G-protein-coupled receptor FPR2/ALX, which triggers potent anti-inflammatory signaling in vivo. Thus, the regulation of FPR2/ALX expression may have pathophysiological and therapeutic relevance. Here, we mapped a nucleotide sequence with strong FPR2/ALX promoter activity. Chromatin immunoprecipitation revealed specificity protein 1 (Sp1) binding to the core promoter. Site-directed mutagenesis of the Sp1 cis-acting element and Sp1 overexpression established that this transcription factor is key for maximal promoter activity, which is instead suppressed by DNA methylation. LXA 4 enhanced FPR2/ALX promoter activity (+74%) and mRNA expression (+87.5%) in MDAMB231 cells. A single nucleotide mutation (A/G) was detected in the core promoter of one subject with history of cardiovascular disease and of his two daughters. This mutation reduced by ∼35-90% the promoter activity in vitro. Moreover, neutrophils from individuals carrying the A/G variant displayed ∼10- and 3-fold reduction in FPR2/ALX mRNA and protein, respectively, compared with cells from their relatives or healthy volunteers expressing the wild-type allele. These results uncover FPR2/ ALX transcriptional regulation and provide the first evidence of mutations that affect FPR2/ALX transcription, thus opening new opportunities for the understanding of the LXA 4-FPR2/ALX axis in human disease.

KW - Inflammation

KW - Lipoxin A receptor

KW - Methylation

KW - Polymorphism

KW - Sp1

UR - http://www.scopus.com/inward/record.url?scp=84857752617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857752617&partnerID=8YFLogxK

U2 - 10.1096/fj.11-198069

DO - 10.1096/fj.11-198069

M3 - Article

C2 - 22131270

AN - SCOPUS:84857752617

VL - 26

SP - 1323

EP - 1333

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 3

ER -